Page last updated: 2024-09-05

temocillin and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

temocillin has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies

Compound Research Comparison

Studies
(temocillin)
Trials
(temocillin)
Recent Studies (post-2010)
(temocillin)
Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
21617789,156187552

Protein Interaction Comparison

ProteinTaxonomytemocillin (IC50)1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)
Platelet-activating factor receptorHomo sapiens (human)0.0003

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baird, A; Chamberlain, PD; Nunn, B1

Trials

1 trial(s) available for temocillin and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Effect of temocillin and moxalactam on platelet responsiveness and bleeding time in normal volunteers.
    Antimicrobial agents and chemotherapy, 1985, Volume: 27, Issue:5

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adult; Bleeding Time; Blood Platelets; Collagen; Humans; Male; Moxalactam; Penicillins; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic

1985